Biotechnology at University of Houston-Downtown

The $20,400 in estimated debt against $47,000 in first-year earnings produces a manageable 0.43 ratio, suggesting this biotechnology degree wouldn't burden graduates excessively. However, these figures come from peer programs nationally, not UH-Downtown's actual outcomes—important context given that the sole Texas school with reported data (University of Houston's flagship) shows graduates earning about $50,000, roughly $3,000 more than what comparable programs elsewhere typically produce.

For a university serving a predominantly working-class student body—half receive Pell grants—biotechnology represents a credible pathway to middle-income employment. The debt load is reasonable, and similar programs typically launch graduates into laboratory, research, or pharmaceutical roles with clear advancement potential. Still, biotechnology bachelor's degrees often serve as stepping stones to graduate work rather than terminal credentials. If your student plans to stop at the bachelor's level, verify what local Houston biotech employers actually hire for versus what requires advanced degrees.

The practical question: can your student access the same Houston biotech market that University of Houston graduates enter? Downtown's 91% admission rate and lower test scores suggest a different peer group than the flagship, but proximity to the Texas Medical Center and Houston's life sciences corridor could offset selectivity concerns. Before committing, identify where UH-Downtown biotechnology graduates actually work—hospital labs, pharma companies, or research positions—to confirm this program delivers on its employment promise.